[Creutzfeldt-Jakob disease].
Tanii
Hisashi
H
Department of Clinical Neuroscience, Psychiatry, Osaka University Graduate School of Medicine.
Takeda
Masatoshi
M
D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D007562:Creutzfeldt-Jakob Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D004203:Disinfection / Q000379:methods; D006801:Humans; D009154:Mutation; D010426:Pentosan Sulfuric Polyester / Q000627:therapeutic use; D018620:PrPSc Proteins / Q000235:genetics / Q000472:pathogenicity
D000927:Anticonvulsants; D000978:Antiparkinson Agents; D018620:PrPSc Proteins; D010426:Pentosan Sulfuric Polyester; D000666:Amphotericin B